Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Thorne

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
The Journal of Experimental Medicine|February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzymeAnnie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Cell Reports|July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large moleculesRobert C Wells, Padma Akkapeddi, Darren Chan, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Molecular Neurodegeneration|June 11, 2022
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microgliaDan Xia, Steve Lianoglou, Thomas Sandmann, et al.
Science Translational Medicine|May 29, 2020
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceJulie C Ullman, Annie Arguello, Jennifer A Getz, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalizationJosé F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Science Translational Medicine|August 14, 2024
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrierScarlett J Barker, Mai B Thayer, Chaeyoung Kim, et al.
Life Science Alliance|January 11, 2022
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19Jose F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
The Journal of Experimental Medicine|February 28, 2022
Molecular architecture determines brain delivery of a transferrin receptor-targeted lysosomal enzymeAnnie Arguello, Cathal S Mahon, Meredith E K Calvert, et al.
Cell Reports|July 24, 2025
Dual targeting of transferrin receptor and CD98hc enhances brain exposure of large moleculesRobert C Wells, Padma Akkapeddi, Darren Chan, et al.
Nature|December 23, 2021
Evolution of enhanced innate immune evasion by SARS-CoV-2Lucy G Thorne, Mehdi Bouhaddou, Ann-Kathrin Reuschl, et al.
Molecular Neurodegeneration|June 11, 2022
Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microgliaDan Xia, Steve Lianoglou, Thomas Sandmann, et al.
Science Translational Medicine|May 29, 2020
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceJulie C Ullman, Annie Arguello, Jennifer A Getz, et al.
Medrxiv : the Preprint Server for Health Sciences|June 2, 2021
Plitidepsin has a positive therapeutic index in adult patients with COVID-19 requiring hospitalizationJosé F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Science Translational Medicine|August 14, 2024
Targeting the transferrin receptor to transport antisense oligonucleotides across the mammalian blood-brain barrierScarlett J Barker, Mai B Thayer, Chaeyoung Kim, et al.
Life Science Alliance|January 11, 2022
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19Jose F Varona, Pedro Landete, Jose A Lopez-Martin, et al.
Nature Communications|August 19, 2023
CD98hc is a target for brain delivery of biotherapeuticsKylie S Chew, Robert C Wells, Arash Moshkforoush, et al.
Pageof 13